Medication info
Rabesto Tablet 20 mg (Rabeprazole Sodium)

Rabesto Tablet 20 mg (Rabeprazole Sodium)

Prescription medicationTablet경구
Ingredient · strength
Rabeprazole Sodium›20mg / 1 tablet
Manufacturer / importer
(주)휴온스
Appearance
Light yellow round enteric-coated tablet
Packaging
28 tablets (14 tablets per pack x 2)
Approval status
Active

MFDS item code 200702549 · Notified 2007.02.28 · Insurance code 670600490

Summary

Main use
Relief of symptoms of gastric ulcer and gastroesophageal reflux disease, and therapeutic effect for Helicobacter pylori infection
Who takes it
Adults
Adult dose
For gastric ulcer and duodenal ulcer: The adult dose is 10 mg of rabeprazole sodium taken orally once daily, which may be increased to 20 mg once daily as needed, up to 8 weeks for gastric ulcers and up to 6 weeks for duodenal ulcers. For erosive or ulcerative gastroesophageal reflux disease: Administer 10 mg or 20 mg once daily for 4 to 8 weeks. If proton pump inhibitors (PPIs) are not effective after 8 weeks of treatment, additional treatment with 10 mg or 20 mg twice daily may be necessary, but 20 mg twice daily is only for patients with confirmed severe mucosal damage. For relief of symptoms of gastroesophageal reflux disease: Administer 10 mg once daily. If symptoms do not improve after 4 weeks, further evaluation is necessary. Once symptoms resolve, an on-demand therapy of 10 mg once daily can be employed to manage any recurrent symptoms. For long-term maintenance therapy of gastroesophageal reflux disease: Depending on the patient, 10 mg or 20 mg may be given orally once daily. For eradication of Helicobacter pylori: Patients infected with Helicobacter pylori should be treated with eradication therapy. It is recommended to administer 20 mg of this medicine along with 500 mg of clarithromycin and 1 g of amoxicillin, twice daily for 7 days. For Zollinger-Ellison syndrome: The recommended initial dose for adults is 60 mg once daily, with adjustments made based on individual patient needs up to a maximum of 120 mg daily. Doses up to 100 mg may be given once daily, while doses of 120 mg should be divided into two doses of 60 mg twice daily. Patients with Zollinger-Ellison syndrome may have been treated with this medicine for up to a year. ● For patients with liver impairment: Adverse reactions of hepatic encephalopathy have been reported in cirrhosis patients. Therefore, caution should be exercised when administering. ● In children: Safety in pediatric patients has not been established. ● In elderly patients: Caution should be exercised because liver function is often impaired.

Ingredients

Manufacturer
(주)휴온스

Efficacy & effects

Relief of symptoms of gastric ulcer and gastroesophageal reflux disease, and therapeutic effect for Helicobacter pylori infection

  • Gastric ulcer
  • duodenal ulcer
  • erosive gastroesophageal reflux disease
  • ulcerative gastroesophageal reflux disease
  • gastrointestinal ulcer
  • Zollinger-Ellison syndrome
View approved original text

This medicine treats stomach ulcers and duodenal ulcers, and helps alleviate symptoms of erosive or ulcerative gastroesophageal reflux disease. Additionally, it is used for long-term maintenance therapy of gastroesophageal reflux disease and shows effectiveness when combined with antibiotics in patients with gastrointestinal ulcers infected by Helicobacter pylori. It is also used in the treatment of Zollinger-Ellison syndrome to improve various gastrointestinal issues. Therefore, this medicine is widely used for treating gastrointestinal ulcers and reflux diseases.

How to take

Adult dose

For gastric ulcer and duodenal ulcer: The adult dose is 10 mg of rabeprazole sodium taken orally once daily, which may be increased to 20 mg once daily as needed, up to 8 weeks for gastric ulcers and up to 6 weeks for duodenal ulcers. For erosive or ulcerative gastroesophageal reflux disease: Administer 10 mg or 20 mg once daily for 4 to 8 weeks. If proton pump inhibitors (PPIs) are not effective after 8 weeks of treatment, additional treatment with 10 mg or 20 mg twice daily may be necessary, but 20 mg twice daily is only for patients with confirmed severe mucosal damage. For relief of symptoms of gastroesophageal reflux disease: Administer 10 mg once daily. If symptoms do not improve after 4 weeks, further evaluation is necessary. Once symptoms resolve, an on-demand therapy of 10 mg once daily can be employed to manage any recurrent symptoms. For long-term maintenance therapy of gastroesophageal reflux disease: Depending on the patient, 10 mg or 20 mg may be given orally once daily. For eradication of Helicobacter pylori: Patients infected with Helicobacter pylori should be treated with eradication therapy. It is recommended to administer 20 mg of this medicine along with 500 mg of clarithromycin and 1 g of amoxicillin, twice daily for 7 days. For Zollinger-Ellison syndrome: The recommended initial dose for adults is 60 mg once daily, with adjustments made based on individual patient needs up to a maximum of 120 mg daily. Doses up to 100 mg may be given once daily, while doses of 120 mg should be divided into two doses of 60 mg twice daily. Patients with Zollinger-Ellison syndrome may have been treated with this medicine for up to a year. ● For patients with liver impairment: Adverse reactions of hepatic encephalopathy have been reported in cirrhosis patients. Therefore, caution should be exercised when administering. ● In children: Safety in pediatric patients has not been established. ● In elderly patients: Caution should be exercised because liver function is often impaired.

Precautions

This medicine should not be used in patients with known allergies or hypersensitivity to certain ingredients. In particular, patients allergic to penicillin or macrolide antibiotics, those taking certain heart-related medications, and pregnant or breastfeeding women should avoid taking this product for safety reasons. Patients with impaired liver function or elderly individuals, as well as those with a history of drug allergies, should use this medicine with caution. This medicine may cause allergic reactions such as itching or rash, and if such symptoms occur, it should be discontinued immediately. Regular blood tests and liver function tests should be undertaken, and any unusual signs should be reported promptly, as side effects may occur in various organs including cardiac, gastrointestinal, nervous, respiratory, and skin systems. Long-term use of this medicine may increase the risk of bone fractures and decrease magnesium levels in the blood; thus, regular monitoring is advisable. Additionally, as it suppresses gastric acid secretion, there may be a slightly increased risk of bacterial infections in the stomach, so if diarrhea persists, consult a healthcare professional. Caution should be exercised while driving or operating machinery due to potential drowsiness or dizziness. There may be interactions with other medications, so inform healthcare providers about any other medications being taken, especially when taking antibiotics, antiviral agents, or anticoagulants. Pregnant or breastfeeding women should avoid this medicine, and its use in children is not recommended due to lack of established safety. Tablets should not be chewed or crushed, and should be swallowed whole. Keep in a sealed container to avoid exposure to air and store at a temperature between 1°C and 30°C. In case of overdose, there is no specific antidote, so appropriate treatment should be administered based on symptoms.

Side effects and when to seek care immediately

Serious side effects

Hives, severe swelling, chest tightness, difficulty breathing, cold sweat, pallor, severe rash with fever, blisters, skin peeling, pain in oral/ocular mucosa, shortness of breath or difficulty breathing, asthma attacks, respiratory abnormalities accompanying cough + fever, yellowing of the skin or eyes, extreme lethargy, sudden and severe headache, thunderclap headache, seizures, confusion of consciousness, visual disturbances, paralysis, markedly reduced urine output

Mild side effects

  • Rash
  • itching
  • red blood cell decrease
  • white blood cell decrease
  • white blood cell increase
  • eosinophil increase
  • neutrophil increase
  • lymphocyte decrease
  • anemia
  • purpura
Show 20 more
  • lymphadenopathy
  • hypochromic anemia
  • pancytopenia
  • agranulocytosis
  • thrombocytopenia
  • hemolytic anemia
  • increased ALT
  • increased AST
  • increased ALP
  • increased γ-GTP
  • increased LDH
  • increased total bilirubin
  • hypertension
  • myocardial infarction
  • abnormal electrocardiogram
  • migraine
  • syncope
  • angina pectoris
  • arrhythmia
  • palpitations

Not everyone experiences these, and they can vary from person to person.

Storage

This medicine should be stored in a sealed container to prevent exposure to air, preferably at a temperature between 1°C and 30°C. Proper storage helps maintain the effectiveness of the medication for a longer period.

Appearance and packaging

Appearance

Light yellow round enteric-coated tablet

Package unit

28 tablets (14 tablets per pack x 2)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.